Ekblad L - Search Results

1

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.

Oshima G, Wennerberg J, Yamatodani T, Kjellén E, Mineta H, Johnsson A, Ekblad L. Oshima G, et al. Among authors: ekblad l. J Cancer Res Clin Oncol. 2012 Mar;138(3):491-9. doi: 10.1007/s00432-011-1127-5. Epub 2011 Dec 23. J Cancer Res Clin Oncol. 2012. PMID: 22193422

2

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.

Yamatodani T, Ekblad L, Kjellén E, Johnsson A, Mineta H, Wennerberg J. Yamatodani T, et al. Among authors: ekblad l. J Cancer Res Clin Oncol. 2009 Mar;135(3):395-402. doi: 10.1007/s00432-008-0475-2. Epub 2008 Sep 24. J Cancer Res Clin Oncol. 2009. PMID: 18813952

3

No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.

Sasaki Y, Kjellén E, Mineta H, Wennerberg J, Ekblad L. Sasaki Y, et al. Among authors: ekblad l. Acta Oncol. 2009;48(7):1062-9. doi: 10.1080/02841860902913553. Acta Oncol. 2009. PMID: 19412811

4

The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.

Sasaki Y, Kjellén E, Ekblad L, Wahlberg P, Mineta H, Wennerberg J. Sasaki Y, et al. Among authors: ekblad l. Oral Oncol. 2012 Jan;48(1):61-6. doi: 10.1016/j.oraloncology.2011.09.003. Epub 2011 Oct 1. Oral Oncol. 2012. PMID: 21963040

5

Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer.

Ekblad L, Johnsson A. Ekblad L, et al. Anticancer Res. 2012 Mar;32(3):783-6. Anticancer Res. 2012. PMID: 22399593

6

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma.

Lindgren G, Ekblad L, Vallon-Christersson J, Kjellén E, Gebre-Medhin M, Wennerberg J. Lindgren G, et al. Among authors: ekblad l. BMC Cancer. 2014 Sep 2;14:648. doi: 10.1186/1471-2407-14-648. BMC Cancer. 2014. PMID: 25182342 Free PMC article.

7

Anti- or pro-proliferation—conditional options for TGF-α and cetuximab in head and neck squamous cell carcinoma.

Ekblad L, Welinder C, Kjellén E, Brun E, Wennerberg J. Ekblad L, et al. Oral Oncol. 2015 Jan;51(1):46-52. doi: 10.1016/j.oraloncology.2014.08.019. Epub 2014 Sep 26. Oral Oncol. 2015. PMID: 25261297

8

EGFR modulates complement activation in head and neck squamous cell carcinoma.

Abu-Humaidan AHA, Ekblad L, Wennerberg J, Sørensen OE. Abu-Humaidan AHA, et al. Among authors: ekblad l. BMC Cancer. 2020 Feb 13;20(1):121. doi: 10.1186/s12885-020-6615-z. BMC Cancer. 2020. PMID: 32054454 Free PMC article.

9

Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.

Bjurberg M, Henriksson E, Brun E, Ekblad L, Ohlsson T, Brun A, Kjellén E. Bjurberg M, et al. Among authors: ekblad l. Cancer Biother Radiopharm. 2009 Jun;24(3):327-32. doi: 10.1089/cbr.2008.0556. Cancer Biother Radiopharm. 2009. PMID: 19538055

10

Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3.

Ekblad L, Lindgren G, Persson E, Kjellén E, Wennerberg J. Ekblad L, et al. BMC Cancer. 2013 Jan 25;13:33. doi: 10.1186/1471-2407-13-33. BMC Cancer. 2013. PMID: 23351302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters